CorMedix Insider Move: Phantom‑Stock Conversion Signals Strategic Shift and Boosts Investor Confidence
CorMedix’s recent phantom‑stock conversion streamlines incentives, shows insider confidence, and could boost pipeline valuation without major dilution.
4 minutes to read